H. Lundbeck A/S (LUN) : Company Profile and SWOT Analysis

Synopsis
World Market Intelligence's 'H. Lundbeck A/S (LUN) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'H. Lundbeck A/S (LUN) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
• Examines and identifies key information and issues about 'H. Lundbeck A/S' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy
• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights
H. Lundbeck A/S (Lundbeck) is a pharmaceutical company, offering treatment for various diseases related to the central nervous system (CNS). The company develops, manufactures and markets pharmaceutical drugs for the treatment of psychiatric and neurological disorders and focuses on therapy areas including Alzheimer's disease, depression and anxiety, alcohol dependence, Parkinson's disease, primary insomnia, schizophrenia and psychotic disorders, epilepsy and acute ischemic stroke. The company operates through several of its subsidiaries, which are present in 57 countries across the world. It has production units in Denmark, Italy and Mexico and research facilities in Denmark and the US. The operations of Lundbeck span over the US, Europe, Middle East, Asia and Latin America. Lundbeck is headquartered in Copenhagen-Valby, Denmark.

Table of Contents
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Operational Efficiency
2.2.4 Solvency
2.2.5 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Turnover – Inventory and Asset
2.3.5 Liquidity
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 Company Statement
6 History
7 Key Employees
8 Key Employee Biographies
9 Locations and Subsidiaries
9.1 Head Office
9.2 Other Locations and Subsidiaries
10 Appendix
10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer

List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries

List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Solvency
Figure 5: Valuation
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Capital Expenditure
Figure 9: Turnover – Inventory and Asset
Figure 10: Liquidity